Biology Reference
In-Depth Information
Plachter B, Sinzger C, Jahn G (1996) Cell types involved in replication and distribution of human
cytomegalovirus. Adv Virus Res 46:195-261
Plotkin SA, Starr SE, Friedman HM et al (1989) Protective effects of Towne cytomegalovirus vaccine
against low-passage cytomegalovirus administered as a challenge. J Infect Dis 159:860-865
Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ (2000) Murine model of
interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence
of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol
74:7496-7507
Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Le Bouteiller P,
Schleussner E, Markert UR (2006) Inhibition of term decidual NK cell cytotoxicity by soluble
HLA-G1. Am J Reprod Immunol 56:275-285
Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH
(1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus
replication during latent infection. J Exp Med 188:1047-1054
Pooley RJ Jr, Peterson L, Finn WG, Kroft SH (1999) Cytomegalovirus-infected cells in routinely
prepared peripheral blood films of immunosuppressed patients. Am J Clin Pathol
112:108-112
Porath A, Schlaeffer F, Sarov I, Keynan A (1987) Cytomegalovirus mononucleosis - a report of
70 cases in a community hospital. Isr J Med Sci 23:268-273
Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke
JP, Mocarski ES, Valantine HA (2006) Acute rejection and cardiac allograft vascular disease is
reduced by suppression of subclinical cytomegalovirus infection. Transplantation 82:398-405
Preblud SR, Alford CA (1990) Rubella. In: Remington JS, Klein JO (eds) Infectious diseases of
the fetus and newborn infant, 3rd edn. W.B. Saunders, Philadelphia, pp 197-240
Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW (2001) A review of genetic dif-
ferences between limited and extensively passaged human cytomegalovirus strains. Rev Med
Virol 11:191-200
Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ,
Borysiewicz LK, Lopez-Botet M, Wilkinson GW, Tomasec P (2007) The human cytomegalo-
virus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells. J Immunol
178:4473-4481
Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ,
Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J,
Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG,
Lindblad AS, Yamaguchi Y et al (1999) The Banff 97 working classification of renal allograft
pathology. Kidney Int 55:713-723
Raeiszadeh M, Webster D, Workman S, Emery VC (2007) The spectrum of CMV associated dis-
ease in patients with common variable immunodeficiency. In: 11th International Betaherpesvirus
Workshop, Toulouse, France, p 12
Ranga U, Woffendin C, Yang ZY, Xu L, Verma S, Littman DR, Nabel GJ (1997) Cell and viral
regulatory elements enhance the expression and function of a human immunodeficiency virus
inhibitory gene. J Virol 71:7020-7029
Rao NA, Zhang J, Ishimoto S (1998) Role of retinal vascular endothelial cells in development of
CMV retinitis. Trans Am Ophthalmol Soc 96:111-123; discussion 124-116
Rapp M, Messerle M, Buhler B, Tannheimer M, Keil GM, Koszinowski UH (1992) Identification
of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant
vaccinia virus. J Virol 66:4399-4406
Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC,
Spivey JR, Paya CV (2001) Allograft rejection predicts the occurrence of late-onset cytomega-
lovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving
prophylaxis with oral ganciclovir. J Infect Dis 184: 1461-1464
Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus latency:
overview. J Clin Virol 25: S23-S36
